The DOI matches its Crossref record; 434 of the 434 references it cites were found in a registry or an index.
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
Open accessAbstract
Should early surgery be conducted for asymptomatic patients with severe AR with an LVEF ≥50% and an LVESD index >25 mm/m 2 ?Early surgery may be considered for asymptomatic patients with severe AR with an LVEF ≥50% and an LVESD index >25 mm/m 2 . C CQ 3Should early operation be conducted for asymptomatic patients with very severe AS and preserved LVEF?If the transvalvular peak velocity is ≥5.0 m/s, the mean transvalvular pressure gradient is ≥60 mmHg, or the AVA is ≤0.6 cm 2 , operation is recommended for asymptomatic patients at low surgical risk. B CQ 4Should concomitant tricuspid valve repair be conducted for patients with mild TR and tricuspid annular dilation (>40 mm or 21 mm/m 2 in diameter)?Concomitant tricuspid valve repair may be considered for patients with mild TR and tricuspid annular dilation (>40 mm or 21 mm/m 2 in diameter).2 C CQ 5Can direct oral anticoaglants (DOACs) be used in patients with AF after bioprosthetic valve replacement?DOACs can be used in patients with AF and bioprosthesis after the 3rd postoperative month.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Rudski, L. G., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,049
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Metadata
- Authors
- Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., Takanashi, S., Tanaka, H., Nakatani, S., Ninami, H., Nishi, H., Hayashida, K., Yaku, H., Yamaguchi, J., Yamamoto, K., Watanabe, H., Abe, Y., Amaki, M., Amano, M., Obase, K., Tabata, M., Miura, T., Miyake, M., Murata, M., Watanabe, N., Akasaka, T., Okita, Y., Kimura, T., Sawa, Y., Yoshida, K., & on behalf of the Japanese Circulation Society Joint Working Group
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2020-10-23
- Volume
- 84
- Issue
- 11
- Pages
- 2037-2119
- ISSN
- 1346-9843 (ISSN-L)
- 1347-4820
- OpenAlex
- W3085589905
- Cited by
- 367
- References
- 434
- FWCI
- 20.39
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease. https://app.cochat.ai/papers/10.1253/circj.cj-20-0135
- The paper
- Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., Takanashi, S., Tanaka, H., Nakatani, S., Ninami, H., Nishi, H., Hayashida, K., Yaku, H., Yamaguchi, J., Yamamoto, K., . . . on behalf of the Japanese Circulation Society Joint Working Group. (2020). JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease. Circulation Journal. https://doi.org/10.1253/circj.cj-20-0135
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
